Fundamental science from Japanese universities and national research institutes.
Osaka University spinoff Reimei has launched the world's first corporate clinical trial of a corneal epithelial cell sheet made from donor-derived iPS cells. Learn how this breakthrough could solve the global corneal donor shortage, restore vision for millions, and where Japan's regenerative medicine regulation stands versus the US FDA.
Japan's Fugaku supercomputer achieved the world's first 100-meter resolution simulation of an entire typhoon lifecycle, from initial vortex to super typhoon over 4 days. The breakthrough revealed tiny vortices invisible to conventional 2km models that delay rapid intensification by a full day, offering critical insights for improving typhoon forecasting in an era of climate change.
Researchers at the University of Tokyo and Tokyo Metropolitan Institute of Medical Science have developed a microneedle patch that delivers COVID-19 vaccines simply by sticking it on the skin. Using a 3D-printed pillar-guided design, the patch achieves 8.3x better loading efficiency and stronger immune response than injections in mouse trials. Explore how this painless, room-temperature-stable technology could transform global vaccination.
Tohoku University and the University of Tokyo have developed DIVE, a multi-agent AI workflow that automatically reads and structures experimental data from scientific paper figures. By extracting over 30,000 data points from 4,000+ papers, the system proposed new hydrogen storage materials in just 2 minutes. Here's how this AI reading team is unlocking data trapped inside research charts.
A joint research team from the University of Yamanashi, Waseda University, and Shinshu University has developed a completely fluorine-free electrolyte membrane for polymer electrolyte fuel cells. Achieving over 100,000 durability cycles—1.3 times that of conventional fluorine-based membranes—this PFAS-free breakthrough could accelerate the global hydrogen economy while addressing environmental regulations.
A Japanese-developed measles-vector vaccine against Nipah virus, a disease with up to 75% fatality, began Phase I clinical trials in Belgium in June 2026. Learn about the approach and Japan's role in global pandemic preparedness.
A Keio University study reveals CGRP antibody drugs reduced migraine frequency by half in about 50% of patients, with over 90% satisfaction. Explore Japan's latest migraine prevention treatments—from monthly injections to upcoming oral medications and neuromodulation—and how they're transforming life for migraine sufferers.
A Tokyo University research team scientifically examined "sleep divorce" through mouse experiments. Which leads to better sleep—co-sleeping or sleeping alone? The surprising findings show optimal sleep environments differ based on social status and genetic background.
A Nagasaki University study reveals nanoplastics transferred through the food chain drastically reduce red sea bream larvae survival rates. With microplastic concentrations 27 times the global average, Japan's coastal waters face an invisible pollution crisis threatening fisheries and marine ecosystems.
A research team at Kanazawa University has developed a next-generation X-ray CT scanner with 5x the resolution of conventional devices (0.08–0.1mm). Capturing images in just 6.5 seconds, this compact device can visualize trabecular bone structure, opening doors for early detection of trigger finger and osteoarthritis. We look at how 20 years of clinical experience led to it.
Kindai University has achieved the world's first full-cycle aquaculture of Nodoguro (Blackthroat seaperch), a high-end deep-sea fish known as the "White Toro." Learn about the decade-long journey, the technical challenges overcome, and what Japan's aquaculture leadership means for global food security.